Evidence map›Paper›PMID 28664159›Full record

ReviewFrontiers in medicine2017

Rediscovering Beta-2 Microglobulin As a Biomarker across the Spectrum of Kidney Diseases.

Christos P Argyropoulos, Shan Shan Chen, Yue-Harn Ng, Maria-Eleni Roumelioti, Kamran Shaffi, Pooja P Singh, Antonios H Tzamaloukas

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Frontiers in medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 162 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
162citing papers in PubMed, 2 pooled it
13.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

162 citing papers in PubMed, 2 syntheses or guidelines pooled it, 291 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

102 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Christos P ArgyropoulosNephrology Division, Department of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, NM, United States.
Shan Shan ChenNephrology Division, Department of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, NM, United States.
Yue-Harn NgNephrology Division, Department of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, NM, United States.
Maria-Eleni RoumeliotiNephrology Division, Department of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, NM, United States.
Kamran ShaffiNephrology Division, Department of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, NM, United States.
Pooja P SinghNephrology Division, Department of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, NM, United States.
Antonios H TzamaloukasNephrology Division, Department of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, NM, United States.
University of New Mexico · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There is currently an unmet need for better biomarkers across the spectrum of renal diseases. In this paper, we revisit the role of beta-2 microglobulin (β

Indexed as

acute kidney injurybeta-2 microglobulinbiomarkerschronic kidney diseaseglomerular filtration ratekidney transplantationmultiple myelomapediatric nephrology

Identifiers

PMID28664159
PMCPMC5471312
OpenAlexW2735466792

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.